null

    Follow us

    Press Releases archive

    Feb. 03, 2014 Recipharm contributes to setting up a new network within contract-based research, development and manufacture in Sweden Recipharm contributes to setting up a new network within contract-based research, development and manufacture in Sweden

    Recipharm has contributed to setting up LSIS (Life Science Innovation Support), a network of privately-owned companies offering innovative services focused on contract-based research, development and manufacture within Life Science. In conjunction with the other companies, we will be contributing to strengthening and developing Swedish Life Science through ensuring healthy and fair competitive conditions in the industry.more

    Jun. 11, 2013 Recipharm AB provides access to Asmasal Clickhaler dossier for Vectura plc Chinese market approval Recipharm AB provides access to Asmasal Clickhaler dossier for Vectura plc Chinese market approval

    Recipharm AB is pleased to announce that it is working with Vectura Group plc to provide access to its licence for the regulatory dossier of Asmasal® for the Chinese regulatory authorities as part of the Chinese market approval process. The regulatory submission will be led by Vectura’s recently announced new strategic joint venture , Tianjin Kinnovata Pharmaceutical Company Limited (Kinnovata): http://www.vectura.com/media/press-releases/2013/13-may-2013.aspx.more

    1 | 2 | 3 | 4 | 5 | 6 | 7 »»